Anteris Technologies Global (NASDAQ:AVR) Sees Large Volume Increase – What’s Next?

Shares of Anteris Technologies Global Corp. (NASDAQ:AVR) saw an uptick in trading volume on Monday. 1,462,601 shares traded hands during trading, an increase of 27% from the average daily volume of 1,147,313 shares. The stock last traded at $5.7950 and had previously closed at $6.31.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on AVR shares. Cantor Fitzgerald reiterated an “overweight” rating and issued a $15.00 price objective on shares of Anteris Technologies Global in a research note on Wednesday, October 14th. Weiss Ratings reissued a “sell (d-)” rating on shares of Anteris Technologies Global in a research note on Wednesday, August 26th. Finally, Barclays upgraded shares of Anteris Technologies Global to a “hold” rating in a research report on Wednesday, October 7th. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $14.00.

Anteris Technologies Global Stock Down 6.7%

The stock has a market capitalization of $574.04 million, a price-to-earnings ratio of -3.02 and a beta of 2.02. The company’s fifty day simple moving average is $7.56 and its 200 day simple moving average is $7.37.

Anteris Technologies Global (NASDAQ:AVR) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.09). The firm had revenue of $1.01 million during the quarter, compared to the consensus estimate of $1.50 million. Anteris Technologies Global had a negative net margin of 4,619.27% and a negative return on equity of 77.69%. During the same quarter last year, the firm earned ($0.58) earnings per share. As a group, analysts anticipate that Anteris Technologies Global Corp. will post -1.21 earnings per share for the current year.

Insider Buying and Selling at Anteris Technologies Global

In related news, major shareholder L1 Capital Pty Ltd purchased 272,695 shares of the company’s stock in a transaction that occurred on Tuesday, October 6th. The stock was acquired at an average price of $7.18 per share, with a total value of $1,957,950.10. Following the completion of the purchase, the insider directly owned 6,358,271 shares in the company, valued at $45,652,385.78. This trade represents a 4.48% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In the last ninety days, insiders acquired 1,554,730 shares of company stock worth $11,694,513 and sold 1,305,369 shares worth $11,380,022. Insiders own 4.50% of the company’s stock.

Hedge Funds Weigh In On Anteris Technologies Global

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Forum Financial Management LP lifted its holdings in Anteris Technologies Global by 266.1% during the 3rd quarter. Forum Financial Management LP now owns 40,008 shares of the company’s stock worth $311,000 after buying an additional 29,081 shares during the period. Farther Finance Advisors LLC boosted its stake in Anteris Technologies Global by 26,789.3% during the third quarter. Farther Finance Advisors LLC now owns 15,058 shares of the company’s stock worth $117,000 after acquiring an additional 15,002 shares in the last quarter. Nantahala Capital Management LLC acquired a new stake in shares of Anteris Technologies Global in the 2nd quarter valued at about $33,325,850. One68 Global Capital LLC bought a new stake in shares of Anteris Technologies Global during the second quarter valued at approximately $128,000. Finally, Bank of America Corp DE acquired a new position in shares of Anteris Technologies Global during the second quarter worth approximately $1,907,000.

Anteris Technologies Global Company Profile

Anteris Technologies Global is a medical device company focused on developing structural heart products for the treatment of heart valve disease. Its primary focus is transcatheter aortic valve replacement (TAVR), a minimally invasive procedure used to replace a diseased aortic valve without traditional open-heart surgery.

The company’s lead product is the DurAVR transcatheter heart valve, which is designed to replicate the function and hemodynamic performance of a healthy human aortic valve.